Flush with cash and eager to gain earlier and easier access to innovative drug technologies, Chinese investors have been pumping money into Western biotech startups over the past two years. But despite this recent trend, U.S. President Donald Trump’s plan to limit... Read More
The Trump administration’s first set of tariffs, which will affect about $800 million worth of imported medical devices and components, will be imposed on July 6, 2018. According to Minnesota’s Star Tribune, for many Minnesota medtech companies, China is the largest global... Read More
This article was also published on MedTech Intelligence. Historically, Myanmar (known as Burma until 1989) has been isolated from the rest of the world. Recent political changes have, however, opened Myanmar up to the West, stimulating economic growth. In particular, the medical device... Read More
Late last year, the US and China held their 27th annual Joint Commission on Commerce and Trade (JCCT) meetings in Washington, DC. The US and China are the world’s two largest economies and are key trading partners. China has the second largest... Read More
This article was also published on MedTech Intelligence. Behind Indonesia and the Philippines, Vietnam is the third most populated country in South East Asia, with a population of more than 90 million. Currently, 5% of Vietnam’s population is 65 and older, but this... Read More
In November 2015, key representatives of the U.S. and Chinese governments met to address bilateral trade issues. Officials discussed a number of important issues that affect the registration of medical products in China. According to the U.S. factsheet on the joint commission, U.S.... Read More
Although the final text of the Trans-Pacific Partnership (TPP) deal has not yet been released, media sources have been speculating about important provisions regarding biologics and medical devices. Fortune magazine has reported that the signatory countries will be able to sign up... Read More
The U.S. Food and Drug Administration (FDA) has released a set of guidance documents for biosimilars. Together, the documents outline how the FDA will assess biologic drug exclusivity, biosimilars, and interchangeability. It is expected that the changes discussed will have a significant... Read More
As of April 15, 2015, the U.S. Food and Drug Administration (FDA) has opened a fast track route for medical device approval called the Expedited Access Pathway (EAP) program. This program will both expedite approval and require less data for certain life... Read More
U.S. Food and Drug Administration News Read More